Given that numerous studies suggest the IL‐6 trans‐signaling pathway may contribute to depression,[33] we treated the CSDS mice with sgp130, an inhibitor of this pathway (Figure S6A, Supporting Information). This evidence concerns the gene IL6 and major depressive disorder.